Putative role of hydromorphone metabolites in myoclonus

Pain

Volumn 51, Issue 2, 1992, Pages 260-261

  Babul, Najik ^a   Darke, Andrew C ^a  

^a Department of Scientific Affairs Purdue Frederick Picketing ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HYDROMORPHONE;

DRUG METABOLISM; HUMAN; LETTER; MYOCLONUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

HUMAN; HYDROMORPHONE; MYOCLONUS;

EID: 0026727105     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(92)90270-L     Document Type: Letter

References (10)

1. Simultaneous determination of hydromorphone, hydrocodone and their 6 α- and 6 β-hydroxy metabolites in urine using selected ion recording with methane chemical ionization
2. Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs and rabbits
3. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report
4. Hydromorphone bioavailability and pharmacokinetic-pharmacodynamic (PK-PD) relationships (abst. POII-2)
5. Sensitive and specific radioimmunoassays for opiates using commercially available methods. I. Methods for the determinations of morphine and hydromorphone
6. Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects
7. Hydromorphone levels and pain control in patients with severe chronic pain
8. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects
9. Studies on drug addiction: with special reference to chemical structures of opium derivatives and allied synthetic substances and their physiological actions
10. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects